Pharma-Bio Serv, Inc.
PBSV
$0.51
-$0.09-15.00%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,403.70% | -181.29% | -159.35% | -154.93% | -100.42% |
| Total Depreciation and Amortization | 10.41% | -1.01% | -6.74% | -40.03% | -30.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.57% | 61.05% | 27.89% | -259.60% | -379.27% |
| Change in Net Operating Assets | -185.15% | -193.09% | -65.53% | 497.11% | 187.00% |
| Cash from Operations | -202.53% | -198.91% | -129.97% | -118.27% | -35.21% |
| Capital Expenditure | -20,500.00% | -- | -2,087.67% | 94.76% | 103.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 143.86% | 684.94% | 71.48% | 150.24% | 24.04% |
| Cash from Investing | 139.86% | 664.52% | 67.74% | 150.14% | 24.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -22.73% | 90.38% | 67.44% | 66.67% | 61.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.13% | 0.09% | 0.09% | 0.09% | 0.09% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -0.07% | 2.21% | 1.40% | 1.45% | 1.49% |
| Foreign Exchange rate Adjustments | 132.85% | -409.38% | -125.69% | -169.35% | -177.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.13% | 210.10% | 8.42% | 132.11% | 9.48% |